Roche Molecular Systems Auditor Salaries in Boulder | Comparably
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on read more
EMPLOYEE
PARTICIPANTS
15
TOTAL
RATINGS
176

Roche Molecular Systems Auditor Salaries in Boulder

The average Roche Molecular Systems Auditor in Boulder earns an estimated $73,707 annually. Roche Molecular Systems' Auditor compensation is $10,689 less than the US average for a Auditor.

In Boulder, The Finance Department at Roche Molecular Systems earns $4,844 more on average than the Operations Department.

Last updated a year ago.

$27k
$41k
$57k
$73k
$282k
$340k
$450k
$73,707
Average Compensation
$73,707
avg. base

Auditor Salaries at Roche Molecular Systems

In Boulder, Auditors earn $4,208 more than Accountants, and $3,015 less than Financial Analysts.

Accounting Manager
$96k*
Senior Accountant
$90k*
Business Analyst
$78k*
Financial Analyst
$77k*
Accountant
$69k*
* estimated salary

Compensation at Roche Molecular Systems by Department

In Boulder, The Finance Department averages $4,844 more than the Operations Department, and $16,563 less than the Sales Department

Sales
$92,307 Avg. total comp.
+$17k
Finance
$75,744 Avg. total comp.
Operations
$70,900 Avg. total comp.
-$5k

Auditor Compensation by Gender (All Companies)

The average female Auditor at companies similar size to Roche Molecular Systems reported making $88,019, while the average male Auditor at similar sized companies reported making $86,640.

Auditor Compensation by Ethnicity (All Companies)

The average Hispanic or Latino Auditor at companies similar size to Roche Molecular Systems reported making $111,857, while the average African American/Black Auditor at similar sized companies reported making $67,169.

How Auditors at Roche Molecular Systems Rate Their Compensation

The majority of Auditors at Roche Molecular Systems believe they're compensated fairly. 100% of Auditors at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems

×
Rate your company